Prof. Arndt Rolfs, CENTOGENE AG, has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a dedicated group of technology innovators, patient advocates, healthcare …
Norgine Ventures completes €2 million financing with pritidenta
LONDON, UK. 7 November 2017, 08:35 AM GMT. Norgine Ventures announced today that it has provided financing of up to €2 million to pritidenta® GmbH, a company based in Leinfelden-Echterdingen, Germany, …
Meet us at BIO-EUROPE!
We are happy and honored sponsors of this year's BIO-EUROPE in Berlin, taking off on Monday, November 6, 2017. Do not miss our panel discussion moderated by Managing Partner Dr. Hubert Birner: Main …
TVM Capital Life Science exits invendo medical GmbH
Ambu announces the acquisition of invendo medical Ballerup, Denmark and Kissing, Germany, October 25, 2017 – Today, Ambu A/S – a leader in the development, manufacturing and …
Panthera Dental is accelerating its growth through investments by TVM Life Science Ventures VII and Emerillon Capital
Quebec City, October 3, 2017 Panthera Dental announced today itspartnership with TVM Life Science Ventures VII and Emerillon Capital venture capitals in order to support its export …
TVM Capital Life Science hosts its 6th annual Life Science Conference in Montreal
Focus on innovation and opportunity for companies and investors Key conference for life science and investing in the region with more than 200 international attendees Montreal, September 19, …
Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement
Merger to create a pre-NDA-stage, NASDAQ-listed, pharmaceutical company focused on the development and commercialization of therapies for serious rare diseases with critical unmet medical …
Proteon Therapeutics Announces $22.0 Million Private Placement
Provides Sufficient Cash into Q4 2019 WALTHAM, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the …
CENTOGENE raises a EUR 25 million Series A financing to fuel innovation and to accelerate growth into personalized medicine
International consortium of investors led by TVM Capital Life Science together with DPE Deutsche Private Equity, Careventures and CIC Capital CENTOGENE will continuously expand its R&D …
Proteon Therapeutics Receives FDA Breakthrough Therapy Designation for Vonapanitase
WALTHAM, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney …